Giuseppe Ciaramella Beam Therapeutics Inc. (BEAM) insider trading activity

Giuseppe Ciaramella is President of Beam Therapeutics Inc.. Currently has a direct ownership of 190,216 shares of BEAM, which is worth approximately $3.23 Million. The most recent transaction as insider was on Dec 22, 2021, when has been sold 2,607 shares (Common Stock) at a price of $7.22 per share, resulting in proceeds of $18,823. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 190K

16.95% 3M change

12.15% 12M change

Total Value Held $3.23 Million

Giuseppe Ciaramella Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 22 2021	BUY Exercise of conversion of derivative security	$18,823 $7.22 p/Share	2,607 Added 3.83%	65,380 Common Stock
Dec 21 2021	SELL Open market or private sale	$2,154,676 $85.83 p/Share	25,104 Reduced 28.57%	62,773 Common Stock
Dec 21 2021	BUY Exercise of conversion of derivative security	$181,251 $7.22 p/Share	25,104 Added 22.22%	87,877 Common Stock
Dec 20 2021	SELL Open market or private sale	$365,423 $85.2 p/Share	4,289 Reduced 6.4%	62,773 Common Stock
Dec 20 2021	BUY Exercise of conversion of derivative security	$30,967 $7.22 p/Share	4,289 Added 6.01%	67,062 Common Stock
Sep 17 2021	BUY Exercise of conversion of derivative security	$12,068 $0.67 p/Share	18,012 Added 22.3%	62,773 Common Stock
Jun 28 2021	SELL Open market or private sale	$8,396,273 $106.85 p/Share	78,580 Reduced 63.71%	44,761 Common Stock
Jun 28 2021	BUY Exercise of conversion of derivative security	$1,335,860 $17.0 p/Share	78,580 Added 38.92%	123,341 Common Stock
Mar 31 2021	BUY Grant, award, or other acquisition	-	25,000 Added 35.84%	44,761 Common Stock
Mar 05 2021	BUY Exercise of conversion of derivative security	$2,700 $0.67 p/Share	4,030 Added 16.94%	19,761 Common Stock
Dec 30 2020	SELL Open market or private sale	$3,688,866 $84.14 p/Share	43,842 Reduced 92.16%	3,731 Common Stock
Dec 30 2020	BUY Exercise of conversion of derivative security	$47,466 $0.85 p/Share	55,842 Added 78.02%	15,731 Common Stock
Sep 30 2020	BUY Exercise of conversion of derivative security	$2,500 $0.67 p/Share	3,731 Added 50.0%	3,731 Common Stock

Giuseppe Ciaramella

President

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BEAM shares.

Notify only if

Value

Insider Trading

Get notified when an Beam Therapeutics Inc. insider buys or sells BEAM shares.

Notify only if

Operation

Value

Type

News

Receive news related to Beam Therapeutics Inc.

Track Activities on BEAM

Account